---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-089805"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2026-08-03T20:15:50+00:00"
generated_at: "2026-08-03T20:17:22.167673+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# TransCode amends preferred stock certificate to remove 60-day notice for ownership limit changes

## Summary
- Second Amended and Restated Certificate of Designation filed on August 3, 2026.
- Removes 60-day notice requirement to change or waive beneficial ownership limitation.
- No other changes to the certificate; no additional securities issued or sold.
- Amendment approved by majority of preferred stockholders and Board of Directors.

## SEC filing metadata
- accession: 0001104659-26-089805
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2026-08-03T20:15:50+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/0001104659-26-089805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926089805/tm2622073d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-089805
- JSON: https://secwatch.observer/filing/0001104659-26-089805.json
- Plain text: https://secwatch.observer/filing/0001104659-26-089805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.